The UPP1 Monoclonal Antibody (CAB0613) is a high-quality antibody developed for reliable detection and analysis of target proteins. This gene encodes a uridine phosphorylase, an enzyme that catalyzes the reversible phosphorylation of uridine (or 2'- deoxyuridine) to uracil and ribose-1-phosphate (or deoxyribose-1-phosphate). The encoded enzyme functions in the degradation and salvage of pyrimidine ribonucleosides.
This antibody is validated for use in WB, ELISA applications and has demonstrated reactivity against Human, Mouse, Rat samples.
Product Name:
UPP1 Monoclonal Antibody
SKU:
CAB0613
Size:
100μL, 20μL
Reactivity:
Human, Mouse, Rat
Clone Number:
ARC2531
Conjugate:
Unconjugated
Immunogen:
Synthetic peptide. This information is considered to be commercially sensitive.
Tested Applications:
WBELISA
Recommended Dilution:
WB
1:500 - 1:1000
ELISA
Recommended starting concentration is 1 μg/mL. Please optimize the concentration based on your specific assay requirements.
Synonyms:
UP, UPP, UPASE, UDRPASE, UPP1
Positive Sample:
HeLa, 293T, Rat large intestine, Rat lung, Rat heart, Mouse large intestine, Mouse lung, Mouse kidney
Cellular Localization:
Cytosol, Nucleoplasm.
Calculated MW:
34kDa
Observed MW:
34kDa
This gene encodes a uridine phosphorylase, an enzyme that catalyzes the reversible phosphorylation of uridine (or 2'- deoxyuridine) to uracil and ribose-1-phosphate (or deoxyribose-1-phosphate). The encoded enzyme functions in the degradation and salvage of pyrimidine ribonucleosides.
Purification Method
Affinity purification
Gene ID
7378
Buffer Information
Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS containing 50% glycerol and 0.05% BSA, preserved with proclin300 or sodium azide, pH 7.3.
Western blot analysis of various lysates using UPP1 Rabbit mAb (CAB0613) at 1:1000 dilution. Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution. Lysates/proteins: 25μg per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit (AbGn00020). Exposure time: 3s.
